Thomas RuppOwner & Principal at Thomas Rupp Consulting UG
Agenda Sessions
CMC Strategies for Complex Oligonucleotides
On DemandView SessionRoundtable Discussion on Managing CMC Activities for Complex and Emerging Oligonucleotide Therapeutics
12:15View Session